Selected Drugs Clear All
MultiCheck Results
- 18
Interactions
Avoid/Use Alternative |
||
|
Depacon
(valproate sodium) + sodium oxybate
(generic) |
||
Avoid/Use Alternativevalproic acid + oxybate use alternative or monitor resp. rate; decr. oxybate IR dose at least 20%; no adjustment if oxybate ER form: combo may incr. oxybate levels, risk of profound CNS and resp. depression, psychomotor impairment, hypotension, syncope, other adverse effects (hepatic metab. possibly inhibited, additive effects) |
||
|
Frova
(frovatriptan) + sodium oxybate
(generic) |
||
Avoid/Use Alternativefrovatriptan + oxybate use alternative or monitor resp. rate; decr. dose of one or both drugs: combo may incr. risk of profound CNS and resp. depression, psychomotor impairment, hypotension, syncope (additive effects) |
||
|
Levsin
(hyoscyamine) + sodium oxybate
(generic) |
||
Avoid/Use Alternativehyoscyamine + oxybate use alternative or monitor resp. rate; decr. dose of one or both drugs: combo may incr. risk of profound CNS and resp. depression, psychomotor impairment, hypotension, syncope (additive effects) |
||
Monitor/Modify Tx |
||
|
Biorphen
(phenylephrine injection) + Emgality (galcanezumab-gnlm)
(galcanezumab) |
||
Monitor/Modify Txphenylephrine injection + galcanezumab monitor BP: combo may incr. risk of HTN (additive effects) |
||
|
Biorphen
(phenylephrine injection) + Frova
(frovatriptan) |
||
Monitor/Modify Txphenylephrine injection + frovatriptan monitor BP: combo may incr. risk of HTN (additive effects) |
||
|
Biorphen
(phenylephrine injection) + lakritze
(licorice (Glycyrrhiza glabra)) |
||
Monitor/Modify Txphenylephrine injection + licorice monitor BP w/ large amounts of licorice: combo may incr. risk of HTN (additive effects) |
||
|
Biorphen
(phenylephrine injection) + Pitocin
(oxytocin) |
||
Monitor/Modify Txphenylephrine injection + oxytocin monitor BP: combo may incr. risk of HTN, incl. life-threatening (additive effects) |
||
|
Emgality (galcanezumab-gnlm)
(galcanezumab) + Frova
(frovatriptan) |
||
Monitor/Modify Txgalcanezumab + frovatriptan monitor BP: combo may incr. risk of HTN (additive effects) |
||
|
Emgality (galcanezumab-gnlm)
(galcanezumab) + lakritze
(licorice (Glycyrrhiza glabra)) |
||
Monitor/Modify Txgalcanezumab + licorice monitor BP w/ large amounts of licorice: combo may incr. risk of HTN (additive effects) |
||
|
Emgality (galcanezumab-gnlm)
(galcanezumab) + Pitocin
(oxytocin) |
||
Monitor/Modify Txgalcanezumab + oxytocin monitor BP: combo may incr. risk of HTN, incl. life-threatening (additive effects) |
||
|
ferrous sulfate
(generic) + Levsin
(hyoscyamine) |
||
Monitor/Modify Txferrous sulfate + hyoscyamine separate admin. by 1h: combo may decr. hyoscyamine levels, efficacy (absorption decreased via chelation) |
||
|
Frova
(frovatriptan) + lakritze
(licorice (Glycyrrhiza glabra)) |
||
Monitor/Modify Txfrovatriptan + licorice monitor BP w/ large amounts of licorice: combo may incr. risk of HTN (additive effects) |
||
|
Frova
(frovatriptan) + Pitocin
(oxytocin) |
||
Monitor/Modify Txfrovatriptan + oxytocin monitor BP: combo may incr. risk of HTN, incl. life-threatening (additive effects) |
||
Caution Advised |
||
|
Depacon
(valproate sodium) + Frova
(frovatriptan) |
||
Caution Advisedvalproic acid + frovatriptan caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects) |
||
|
Depacon
(valproate sodium) + Levsin
(hyoscyamine) |
||
Caution Advisedvalproic acid + hyoscyamine caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects) |
||
|
Frova
(frovatriptan) + Levsin
(hyoscyamine) |
||
Caution Advisedfrovatriptan + hyoscyamine caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects) |
||
|
Levsin
(hyoscyamine) + Urecholine
(bethanechol) |
||
Caution Advisedhyoscyamine + bethanechol caution advised: combo may decr. efficacy of both drugs (antagonistic effects) |
||
Additional Considerations |
||
|
green coffee
in green coffee bean extract
|
||
|
add a caffeine product to Interaction Check esp. if caffeine amount in green coffee product is >100 mg; some products are low-caffeine/decaffeinated |
||
|
hyoscyamine
in Levsin
|
||
|
caution advised w/ concurrent oral drugs requiring rapid onset; hyoscyamine delays gastric emptying, may alter absorption of concomitant oral drugs |
||
|
lamivudine
|
||
|
avoid combo of lamivudine oral solution w/ oral products containing sorbitol; may give lamivudine tab formulation or monitor virologic response more frequently if combo cannot be avoided; sorbitol may decr. bioavailability of lamivudine, resulting in decr. levels, efficacy |
||